| NAME | : | Binimetinib |
| BOBOT | : | 441.233 |
| RUMUS | : | C17H15BrF2N4O3 |
| THERAPEUTIC INDC | : | On June 27, 2018, the Food and Drug Administration approved encorafenib and binimetinib in combination patients with unresectable or metastatic m... |
| CATEGORIES | : | UGT1A1 Substrates |
| STRUCTURE | : |  |